EP
NVRO

Eversept Partners’s NEVRO CORP. NVRO Stock Holding History

Eversept Partners’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-313,780
Closed -$1.75M – 81
2024
Q3 		$1.75M Sell
313,780
-185,615
-37% -$1.3M 0.12% 59
2024
Q2 		$4.2M Buy
499,395
+109,732
+28% +$1.17M 0.29% 51
2024
Q1 		$5.63M Buy
+389,663
New +$6.44M 0.38% 46
2022
Q1 		– Sell
-66,074
Closed -$5.36M – 109
2021
Q4 		$5.36M Buy
+66,074
New +$6.62M 0.34% 62
2018
Q3 		– Sell
-47,279
Closed -$3.78M – 74
2018
Q2 		$3.78M Sell
47,279
-13,571
-22% -$1.13M 1.73% 18
2018
Q1 		$5.27M Sell
60,850
-4,000
-6% -$323K 2.45% 16
2017
Q4 		$4.48M Buy
+64,850
New +$5.19M 2.58% 14

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Eversept Partners's NVRO Position: Q4 2024 in Review

Eversept Partners sold out of NEVRO CORP. (NVRO) in Q4 2024, closing a stake of 313,780 shares — an estimated $1.75M sold.

Eversept Partners first reported a position in NVRO in Q4 2017 and held it in 7 quarters. The position peaked at $5.63M in Q1 2024. 129 funds tracked by Wall St. Rank hold NVRO as of Q4 2024.

  • Eversept Partners reported no remaining NEVRO CORP. position as of Q4 2024 after selling out during the quarter.
  • Eversept Partners sold 313,780 NEVRO CORP. shares in Q4 2024, an estimated $1.75M.
  • Eversept Partners first reported a position in NEVRO CORP. in Q4 2017 and held it in 7 quarters.
  • Eversept Partners's NEVRO CORP. position peaked at $5.63M in Q1 2024.
  • 129 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2024.

Based on Eversept Partners's 13F filing for Q4 2024, filed 14 Feb 2025.